Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000401

Drug Information
NameOxytetracycline    
SynonymsDB00595; 105145-10-6; Oxitetracyclin; UNII-SLF0D9077S; Oxytetracycline [INN]; Ursocycline; HSDB 3145; Oxymykoin; Unimycin; AC1NQZMP; 15251-48-6; CID5282186; Ossitetraciclina [DCIT]; CHEBI:27701; 7179-50-2 (calcium (1:1) salt); LS-93860; SPBio_001055; Geomycin (Streptomyces vimosus); Oxytetracycline (internal use); STOCK1N-50853; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; Oxymycin; MLS000069429; AC1O52HP; 2058-46-0 (mono-hydrochloride); NCGC00091268-04; Terramycin, Liquamycin, Oxytetracycline; Tetracycline, 5-hydroxy-; MolPort-002-524-946; Oxyterracyne; Prestwick1_000307; CHEMBL1517; Ursocyclin; Oxytetracycline (anhydrous); Oxytetracycline amphoteric; 6153-64-6 (di-hydrate); (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; Tarocyn; 21645-09-0; Prestwick3_000307; Solkaciclina; Pennox 200; Oxytetracyclinum [INN-Latin]; BSPBio_002151; 106216-57-3; CID6426716; (2E,4S,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6S,12aS)-; AKOS001632631; 64038-91-1 (sulfate (2:1)); BRN 2714587; C06624; MolPort-005-934-326; Macocyn; AC-12777; 69766-62-7 (hydrochloride salt); OTC; 52214-46-7; Ryomycin; DivK1c_000225; KBio1_000225; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-; 79-57-2; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-; SPBio_002493; NCI-C56473; NSC-9169; 103351-03-7; Oxitetraciclina; SMR000059000; Oxytetracid; KBio2_001535; Oxitetraciclina [INN-Spanish]; Oxytetracyclin; OTC (antibiotic); 856305-69-6; Terramitsin; Teravit; Geomycin; Ossitetraciclina; Tarosin; Biostat PA; Adamycin; Spectrum5_001148; 4-14-00-02633 (Beilstein Handbook Reference); Oxyterracin; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4-alpha,4a-alpha,5-alpha,5a-alpha,6-beta,12a-alpha))-; Oxyterracine; KBio3_001651; Dabicycline; 102287-29-6; Oxytetracyclinum; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-; oxytetracycline; S1773_Selleck; Spectrum2_000988; Hydroxytetracycline; Terramycin im; Imperacin; Oxytetracycline HCl; KBioSS_001535; Spectrum4_000466; Mycoshield TMQTHC 20; Oxitetracycline; Antibiotic TM 25; Fanterrin; Lenocycline; 6153-65-7 (di-hydrochloride salt, di-hydrate); Dalimycin; LA 200; KBio2_006671; TM 5; AC1NS4NE; Oxytetracycline anhydrous; Prestwick0_000307; Oxypam; Terramycin Q50; KBioGR_000912; Spectrum3_000536; CID5280972; Biostat; CID5353856; (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; UNII-X20I9EN955; Riomitsin; Oxitetracyclinum; 1405-95-4; Tetran; Proteroxyna; NCGC00091268-05; NINDS_000225; BSPBio_000274; Oxytetracycline calcium; AC1NQXTY; Geotilin; Vendarcin; IDI1_000225; EINECS 201-212-8; KBio2_004103; Liquamycin LA 200; BPBio1_000302; Prestwick2_000307; Oksisyklin; 5-Hydroxytetracycline; C22H24N2O9; Terramycin; Oxacycline; 96310-42-8; Terrafungine; (2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; LMPK07000005; Spectrum_001055    
Trade NameTerramycin    
CompanyPfizer Pharmaceuticals    
IndicationBacterial infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntibacterial Agents    
CAS NumberCAS 79-57-2
FormularC22H24N2O9    
PubChem Compound IDCID 6426716.    
PubChem Substance IDSID 10486593.    
ChEBI27701;    
SuperDrug ATC IDD06AA03;    
SuperDrug CAS ID000079572;    
Target30S ribosomal subunitBinder[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 060634 To Reference
Ref 2Detection of tetracycline resistance genes by PCR methods. Methods Mol Biol. 2004;268:3-13. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543